Holen Sie sich die Stockscreener-App
3.95
8.37%
0.305
Handel nachbörslich:
3.86
-0.09
-2.28%
Conexeu Sciences Inc Aktie (CNXU) Neueste Nachrichten
Form 4 Conexeu Sciences Inc. For: 28 September By Investing.com - Investing.com India
Form 4 Conexeu Sciences Inc. For: 28 September By Investing.com - Investing.com Nigeria
Form 4 Conexeu Sciences Inc. For: 28 September By Investing.com - Investing.com South Africa
Form 4 Conexeu Sciences Inc. For: 28 September By Investing.com - Investing.com Australia
Form 4 Conexeu Sciences Inc. For: 28 September By Investing.com - Investing.com UK
At $0.001 a share, a Conexeu Sciences (CNXU) executive exercises rights to acquire stock. - stocktitan.net
Conexeu Sciences (NASDAQ:CNXU): What The Bearish Surge Signals? - Kalkine Media
Conexeu Sciences Revises Prospectus for 9.48 Million Shares with Latest Quarterly Report (NASDAQ: CNXU) - Kalkine Media
Conexeu (Nasdaq: CNXU) consultant gets 500K shares at $0.001; more hinge on FDA filing - Stock Titan
Conexeu Sciences (NASDAQ: CNXU) Reports $7.73M Quarterly Loss, Highlights Funding Challenges - Kalkine Media
CNXU 8-K FilingsCONEXEU SCIENCES INC SEC 8-K - Stock Titan
Conexeu Sciences Director Purcell Lynn Sebastian Executes 217,608-Share Deal at $2.30 Each - Kalkine Media
Conexeu Sciences (CNXU) director exercises 217K-share warrant at $2.30 - Stock Titan
Ambarella Q2 Revenue Rises 12% as Net Loss Narrows Sharply - minichart.com.sg
Investment fund caps Conexeu Sciences (CNXU) stake below 10% - Stock Titan
Near-10% stake in Conexeu (CNXU) tied to warrant cap - Stock Titan
Conexeu Sciences (NASDAQ:CNXU) Shares Down 5.2%Here's What Happened - marketbeat.com
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture - TradingView
Conexeu Steps Up Investor Outreach Ahead of Key Regulatory Milestones - TipRanks
Conexeu Sciences Sets September and October 2026 Conference Schedule - The Manila Times
At Nasdaq headquarters, a biotech company will present Sept. 9, then attend two more events. - Stock Titan
Conexeu Sciences (CNXU) pays consultants with $88K in stock - Stock Titan
Conexeu Sciences Inc.: Fundamental Analysis and Financial Ratings | CNXU | US20715F1003 - marketscreener.com
Here's Why We're Not Too Worried About Conexeu Sciences' (NASDAQ:CNXU) Cash Burn Situation - webull.com
The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts - Eastern Progress
A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It. - The Spec
The Biggest Winners Don't Compete in a Category. They Rewrite It. One Company Is Betting It Can Too. - marketscreener.com
Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration - Moomoo
Jeffrey Sharpe Discloses Investment at Conexeu Sciences Inc. with 5.4% Stake - TradingView
2.3M-share stake in Conexeu Sciences (CNXU) revealed by single investor - Stock Titan
Conexeu (CNXU) director gets $0.001 warrants tied to Nasdaq, FDA goals - Stock Titan
CNXU - Finviz
A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It. - GlobeNewswire
Conexeu Sciences Inc. (CNXU) BetaZacks.com - Zacks Investment Research
CNXU : Conexeu Sciences Inc. Key Company Details - Zacks Investment Research
Conexeu Sciences (CNXU) investor reports 12.3% stake and warrant-linked shares - Stock Titan
Conexeu Sciences Inc. (CNXU) investor discloses 5.5% stake in Schedule 13G filing - Stock Titan
OnePointTwo Capital Ventures (CNXU) discloses 1.88M-share Conexeu Sciences stake - Stock Titan
One Platform, Five Markets: Insights Into Conexeu Sciences Inc. - smallcapasia.com
The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For - marketscreener.com
The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For - GlobeNewswire
Conexeu to Present at 2026 Controversies & Conversations in Laser and Cosmetic Surgery Symposium on the Role of the Extracellular Matrix in Tissue Regeneration - marketscreener.com
Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It - marketscreener.com
Conexeu Highlights ECM-Based Regenerative Platform Ahead of 2026 Aesthetics Symposium - TipRanks
Conexeu to Present at 2026 Controversies & Conversations in Laser & Cosmetic Surgery Symposium on the Role of the Extracellular Matrix in Tissue Regeneration - The Manila Times
Beyond volume: Conexeu to discuss the body's repair process - Stock Titan
Conexeu Sciences Ord Shs (CNXU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
GT Biopharma’s TriKE® Program: Pipeline, Progress, & What’s Ahead - smallcapasia.com
Price to earnings forward of Conexeu Sciences Inc. – NASDAQ:CNXU - TradingView
Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One - Investing News Network
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):